Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients.
Canino F, Tornincasa A, Bettelli S, Manfredini S, Barbolini M, Moscetti L, Omarini C, Toss A, Tamburrano F, Antonelli G, Baglio F, Belluzzi L, Martinelli G, Natalizio S, Ponzoni O, Dominici M, Piacentini F. Canino F, et al. Among authors: tornincasa a. Int J Mol Sci. 2024 Feb 20;25(5):2490. doi: 10.3390/ijms25052490. Int J Mol Sci. 2024. PMID: 38473737 Free PMC article.
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Dieci MV, Carbognin L, Miglietta F, Canino F, Giorgi CA, Cumerlato E, Amato O, Massa D, Griguolo G, Genovesi E, Garufi G, Giannarelli D, Tornincasa A, Trudu L, Michieletto S, Saibene T, Lo Mele M, Fassan M, Zarrilli G, Piacentini F, Bria E, Guarneri V. Dieci MV, et al. Among authors: tornincasa a. Br J Cancer. 2023 Jan;128(2):398. doi: 10.1038/s41416-022-02087-9. Br J Cancer. 2023. PMID: 36460777 Free PMC article. No abstract available.
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Dieci MV, Carbognin L, Miglietta F, Canino F, Giorgi CA, Cumerlato E, Amato O, Massa D, Griguolo G, Genovesi E, Garufi G, Giannarelli D, Tornincasa A, Trudu L, Michieletto S, Saibene T, Lo Mele M, Fassan M, Zarrilli G, Piacentini F, Bria E, Guarneri V. Dieci MV, et al. Among authors: tornincasa a. Br J Cancer. 2023 Jan;128(2):266-274. doi: 10.1038/s41416-022-02050-8. Epub 2022 Nov 17. Br J Cancer. 2023. PMID: 36396818 Free PMC article.
Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist.
Canino F, Omarini C, Cerma K, Moscetti L, Tornincasa A, Trudu L, Dominici M, Piacentini F. Canino F, et al. Among authors: tornincasa a. Clin Breast Cancer. 2022 Jun;22(4):289-299. doi: 10.1016/j.clbc.2022.02.002. Epub 2022 Feb 7. Clin Breast Cancer. 2022. PMID: 35246390 Review.